You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Solid Tumor Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot
The global Solid Tumor Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Solid Tumor Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Small Molecules
Enzymes
Blood and Blood Components
Gene Therapy
Recombinant Proteins
Somatic Cells
Tissues
Vaccines
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca
Abbott Laboratories
Amgen Limited & Amgen Ireland Limited
Biogen
Baxter
Bristol-Myers Squibb Company
F. Hoffmann-La Roche
Eli Lilly and Company
Johnson & Johnson
GlaxoSmithKline
Celgene Corporation
Pfizer
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oncology
Radiology
Neurology
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Solid Tumor Drugs Industry
Figure Solid Tumor Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Solid Tumor Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Solid Tumor Drugs
1.2.2 Downstream
Table Application Segment of Solid Tumor Drugs
Table Global Solid Tumor Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Solid Tumor Drugs Market by Type
3.1 By Type
3.1.1 Small Molecules
Table Major Company List of Small Molecules
3.1.2 Enzymes
Table Major Company List of Enzymes
3.1.3 Blood and Blood Components
Table Major Company List of Blood and Blood Components
3.1.4 Gene Therapy
Table Major Company List of Gene Therapy
3.1.5 Recombinant Proteins
Table Major Company List of Recombinant Proteins
3.1.6 Somatic Cells
Table Major Company List of Somatic Cells
3.1.7 Tissues
Table Major Company List of Tissues
3.1.8 Vaccines
Table Major Company List of Vaccines
3.2 Market Size
Table Global Solid Tumor Drugs Market 2016-2020, by Type, in USD Million
Figure Global Solid Tumor Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Solid Tumor Drugs Market 2016-2020, by Type, in Volume
Figure Global Solid Tumor Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Solid Tumor Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Solid Tumor Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AstraZeneca (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.1.2 AstraZeneca Products & Services
4.1.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Abbott Laboratories (Company Profile, Sales Data etc.)
4.2.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
4.2.2 Abbott Laboratories Products & Services
4.2.3 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Amgen Limited & Amgen Ireland Limited (Company Profile, Sales Data etc.)
4.3.1 Amgen Limited & Amgen Ireland Limited Profile
Table Amgen Limited & Amgen Ireland Limited Overview List
4.3.2 Amgen Limited & Amgen Ireland Limited Products & Services
4.3.3 Amgen Limited & Amgen Ireland Limited Business Operation Conditions
Table Business Operation of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Biogen (Company Profile, Sales Data etc.)
4.4.1 Biogen Profile
Table Biogen Overview List
4.4.2 Biogen Products & Services
4.4.3 Biogen Business Operation Conditions
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Baxter (Company Profile, Sales Data etc.)
4.5.1 Baxter Profile
Table Baxter Overview List
4.5.2 Baxter Products & Services
4.5.3 Baxter Business Operation Conditions
Table Business Operation of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
4.6.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
4.6.2 Bristol-Myers Squibb Company Products & Services
4.6.3 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.7.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.7.2 F. Hoffmann-La Roche Products & Services
4.7.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.8.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.8.2 Eli Lilly and Company Products & Services
4.8.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Johnson & Johnson (Company Profile, Sales Data etc.)
4.9.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.9.2 Johnson & Johnson Products & Services
4.9.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.10.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.10.2 GlaxoSmithKline Products & Services
4.10.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Celgene Corporation (Company Profile, Sales Data etc.)
4.11.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
4.11.2 Celgene Corporation Products & Services
4.11.3 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Pfizer (Company Profile, Sales Data etc.)
4.12.1 Pfizer Profile
Table Pfizer Overview List
4.12.2 Pfizer Products & Services
4.12.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Solid Tumor Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Solid Tumor Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Solid Tumor Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Solid Tumor Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Solid Tumor Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Solid Tumor Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Solid Tumor Drugs Market Concentration, in 2020
Figure Europe Solid Tumor Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Solid Tumor Drugs MMarket Concentration, in 2020
Figure South America Solid Tumor Drugs Market Concentration, in 2020
Figure Middle East & Africa Solid Tumor Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oncology
Figure Solid Tumor Drugs Demand in Oncology, 2016-2020, in USD Million
Figure Solid Tumor Drugs Demand in Oncology, 2016-2020, in Volume
6.1.2 Demand in Radiology
Figure Solid Tumor Drugs Demand in Radiology, 2016-2020, in USD Million
Figure Solid Tumor Drugs Demand in Radiology, 2016-2020, in Volume
6.1.3 Demand in Neurology
Figure Solid Tumor Drugs Demand in Neurology, 2016-2020, in USD Million
Figure Solid Tumor Drugs Demand in Neurology, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Solid Tumor Drugs Demand in Others, 2016-2020, in USD Million
Figure Solid Tumor Drugs Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Solid Tumor Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Solid Tumor Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Solid Tumor Drugs Market Share in 2026, by Application, in USD Million
Table Solid Tumor Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Solid Tumor Drugs Market Growth 2021-2026, by Application, in Volume
Table Solid Tumor Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Solid Tumor Drugs Production 2016-2020, by Region, in USD Million
Table Solid Tumor Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Solid Tumor Drugs Market 2016-2020, by Region, in USD Million
Table Global Solid Tumor Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Solid Tumor Drugs Market 2016-2020, by Region, in Volume
Table Global Solid Tumor Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Solid Tumor Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Solid Tumor Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Solid Tumor Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Solid Tumor Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Solid Tumor Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Solid Tumor Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Solid Tumor Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Solid Tumor Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Solid Tumor Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Solid Tumor Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Solid Tumor Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Solid Tumor Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Solid Tumor Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Solid Tumor Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Solid Tumor Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Solid Tumor Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Solid Tumor Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Solid Tumor Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Solid Tumor Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Solid Tumor Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Solid Tumor Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Solid Tumor Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 97